Physician

Anthony L Doerr, MD

According to 2025 Medicare claims, Anthony Doerr, MD (NPI: 1194773929) practices urology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is WEST FLORIDA MEDICAL CENTER CLINIC, PA (NPI: 1568452688; TIN: 592193856) and primary practice location at 32514-6050.

Doerr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,547 traditional Medicare patients, billed 33,916 HCPCS/CPT codes, and received $1,388,603 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,862 prescription claims across 602 beneficiaries totaling $333,620 in drug costs, led by Gemtesa (Vibegron). DME data shows 191 claims. Open Payments data shows 62 records totaling $1,173. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $450,949 to $1,388,603. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $176,934 and ending at $333,620. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,654 to $1,982.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,264	8,758	$450,949
2016	1,404	9,543	$491,719
2017	1,491	9,928	$513,470
2018	1,521	9,231	$461,057
2019	1,517	9,636	$451,311
2020	1,618	10,047	$442,414
2021	1,493	8,819	$469,484
2022	1,550	21,553	$914,574
2023	1,569	32,307	$1,335,276
2024	1,547	33,916	$1,388,603

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	367	1,347	$176,934
2016	422	1,475	$194,133
2017	502	1,782	$254,905
2018	516	1,889	$307,713
2019	554	2,022	$327,217
2020	549	1,936	$291,851
2021	469	1,463	$195,165
2022	460	1,342	$159,488
2023	527	1,598	$254,096
2024	602	1,862	$333,620

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	27	231	$67,163
2016	13	188	$70,964
2017	15	165	$54,313
2018	19	196	$52,679
2019	15	238	$77,546
2020	21	233	$100,443
2021	21	206	$99,378
2022	19	186	$55,790
2023	16	171	$37,007
2024	17	191	$56,959

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,271	1,961	$88
87500	Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique	626	1,093	$34
87150	Identification of organisms by genetic analysis, amplified probe technique	626	13,105	$34
51798	Ultrasound measurement of bladder capacity after voiding	984	1,428	$8
81002	Urinalysis, manual test	1,402	2,434	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	170	9,329	$145,385
Xtandi	Enzalutamide	11	315	$79,160
Myrbetriq	Mirabegron	88	5,044	$72,172
Tamsulosin Hcl	Tamsulosin Hcl	354	30,001	$6,119
Finasteride	Finasteride	358	31,879	$5,357

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	17	85	$33,805
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	13	$20,063
A4349	Male external catheter, with or without adhesive, disposable, each	N	N/R	12	$902
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	14	$831
A4332	Lubricant, individual sterile packet, each	N	N/R	39	$808

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,173	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony L. Doerr, MD?

Tedicare shows public-source Medicare data for Anthony L. Doerr, MD (NPI 1194773929), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony L. Doerr, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony L. Doerr, MD?

Anthony L. Doerr, MD is linked to WEST FLORIDA MEDICAL CENTER CLINIC, PA (billing NPI 1568452688) in the available physician profile data.

Does Anthony L. Doerr, MD have Open Payments data?

Anthony L. Doerr, MD has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.